AU3954799A - Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments - Google Patents

Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments

Info

Publication number
AU3954799A
AU3954799A AU39547/99A AU3954799A AU3954799A AU 3954799 A AU3954799 A AU 3954799A AU 39547/99 A AU39547/99 A AU 39547/99A AU 3954799 A AU3954799 A AU 3954799A AU 3954799 A AU3954799 A AU 3954799A
Authority
AU
Australia
Prior art keywords
medicaments
carriers
cyclodextrin derivatives
alkylated cyclodextrin
acylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39547/99A
Inventor
Fumitoshi Hirayama
Hiroshi Kawaji
Akira Kondo
Masaaki Ohta
Yasuhiro Okamoto
Kaneto Uekama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU3954799A publication Critical patent/AU3954799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU39547/99A 1998-05-29 1999-05-27 Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments Abandoned AU3954799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16446598 1998-05-29
JP10/164465 1998-05-29
PCT/JP1999/002806 WO1999062958A1 (en) 1998-05-29 1999-05-27 Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments

Publications (1)

Publication Number Publication Date
AU3954799A true AU3954799A (en) 1999-12-20

Family

ID=15793704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39547/99A Abandoned AU3954799A (en) 1998-05-29 1999-05-27 Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments

Country Status (4)

Country Link
EP (1) EP1084149A1 (en)
JP (1) JP2002517521A (en)
AU (1) AU3954799A (en)
WO (1) WO1999062958A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
JP2003063965A (en) * 2001-06-13 2003-03-05 Otsuka Pharmaceut Factory Inc Cilostazol aqueous composition for injection
WO2003059393A1 (en) * 2002-01-15 2003-07-24 Altana Pharma Ag Pantoprazole cyclodextrin inclusion complexes
PT1608344E (en) 2003-03-28 2010-09-02 Ares Trading Sa Oral formulations of cladribine
FR2903987B1 (en) * 2006-07-21 2012-12-21 Centre Nat Rech Scient NOVEL AMPHIPHILIC CYCLODEXTRIN DERIVATIVES, THEIR USE IN THE PHARMACEUTICAL, COSMETIC, FOOD SECTORS AND THEIR APPLICATION TO THE PRODUCTION OF NEW NANOSYSTEMS
CN118078742A (en) 2015-10-20 2024-05-28 斯帕方有限公司 Aqueous compositions comprising dantrolene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201783B (en) * 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
DE3810737A1 (en) * 1988-03-30 1989-10-12 Macherey Nagel Gmbh & Co Kg SUBSTITUTED CYCLODEXTRINE

Also Published As

Publication number Publication date
EP1084149A1 (en) 2001-03-21
JP2002517521A (en) 2002-06-18
WO1999062958A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
AU2480499A (en) Calcification-resistant medical articles
AU7995300A (en) Dithiolane derivatives
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU1447601A (en) Product packaging arrangement having retainer
AU1489001A (en) Pocket design for absorbent article
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU6014900A (en) Staurosporin derivatives
AU7581300A (en) Highly stable packaging substrates and brominated indane derivatives
AU6461599A (en) Packaging for medicaments
AU1698601A (en) Packaged skin product
AU7662600A (en) 13-alkyl epothilone derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU2291901A (en) Pocket design for absorbent article
AU6263400A (en) Polyisocyanate-polyaddition products
AU1068199A (en) Individually packaged absorbent article
AU2291899A (en) Fast dissolving pharmaceutical products
AU1548101A (en) Sphingosine derivatives
AU3954799A (en) Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments
AU7705100A (en) Conveyor carrier
AU2001274535A1 (en) Hydroxyformamidine derivatives and medicines containing the same
AU1186199A (en) Individually packaged absorbent article
AU3758000A (en) Packaged article
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase